A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis
Open Access
- 26 June 2026
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 49 (1) , 156
Abstract
Severe traumatic brain injury (TBI) is associated with high mortality and long-term disability. Inflammation is central to TBI pathophysiology, yet early dynamics of inflammatory mediators in blood and cerebrospinal fluid (CSF) remain incompletely understood, and commonly used assay platforms have rarely been directly compared. We aimed to characterize the inflammatory response in blood and CSF during the first week after severe TBI and to assess agreement between electrochemiluminescence (ECL) and proximity extension assay (PEA). In this prospective observational study, adults with severe TBI ( n = 21) were recruited. Plasma and CSF samples were collected at two time points: days 1–3 and days 4–8. Orthopedic patients with minor extremity fractures ( n = 11) served as controls. Inflammatory mediator levels were quantified using ECL (11 mediators) and PEA (45 mediators). Group differences, temporal changes, and inter-platform agreement were analyzed. In plasma, 13 mediators were increased and 3 decreased, while in CSF, 19 were increased and 3 decreased during the first week post-injury. Key mediators (IL-6, IL-8, IL-10) were consistently elevated in both compartments. When comparing analytic methods, ECL and PEA showed strong cross-platform correlations for IL-8 and IL-10 in both plasma and CSF, whereas IL-13 showed weak, non-significant correlation. However, limited interchangeability between platforms and platform-related differences across compartments and time points were also observed. Severe TBI is associated with marked, temporal and compartmentalized inflammatory response during first post-injury, particularly in CSF. Comparison of ECL and PEA showed limited interchangeability, underscoring the importance of platform awareness and interpretation in TBI biomarker studies. Clinical trial number: Not applicable.Keywords
Funding Information
- Lunds Universitet
This publication has 40 references indexed in Scilit:
- Parsimonious immune-response endotypes and global outcome in patients with traumatic brain injuryEBioMedicine, 2024
- Single-cell transcriptomics of human traumatic brain injury reveals activation of endogenous retroviruses in oligodendrogliaCell Reports, 2023
- Comparison of multiplexed protein analysis platforms for the detection of biomarkers in the nasal epithelial lining fluid of healthy subjectsJournal of Immunological Methods, 2023
- Inflammatory cytokines associated with outcomes in orthopedic trauma patients independent of New Injury Severity score: A pilot prospective cohort studyJournal of Orthopaedic Research, 2021
- Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide AnalysisMolecular & Cellular Proteomics, 2021
- How to deal with non-detectable and outlying values in biomarker research: Best practices and recommendations for univariate imputation approachesComprehensive Psychoneuroendocrinology, 2021
- The immunological response to traumatic brain injuryJournal of Neuroimmunology, 2019
- Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injuryClinical Neurology and Neurosurgery, 2016
- Dealing with Danger in the CNS: The Response of the Immune System to InjuryNeuron, 2015
- Blood–Brain Barrier Pathophysiology in Traumatic Brain InjuryTranslational Stroke Research, 2011